Behera B, Rout B, RajashreePanigrahy , Kar S, Sahoo D, Sahu K
Egypt J Med Hum Genet. 2023; 23(1):7.
PMID: 37521837
PMC: 8769779.
DOI: 10.1186/s43042-022-00225-9.
Hussein A, Bakr E, Al-Jumaili M
J Int Med Res. 2022; 50(11):3000605221133147.
PMID: 36329597
PMC: 9638682.
DOI: 10.1177/03000605221133147.
Casman C, Fitriani N, Gunawan D, Rohayati R
Florence Nightingale J Nurs. 2022; 30(3):301-309.
PMID: 36106813
PMC: 9623127.
DOI: 10.5152/FNJN.2022.21260.
Chowdhry M, Hussain M, Singh P, Lekshmi M, Agrawal S, Kanwar M
Transfus Apher Sci. 2022; 61(6):103497.
PMID: 35842293
PMC: 9247114.
DOI: 10.1016/j.transci.2022.103497.
Vargas-Alarcon G, Ramirez-Bello J, Posadas-Sanchez R, Rojas-Velasco G, Lopez-Reyes A, Martinez-Gomez L
Biomolecules. 2022; 12(4).
PMID: 35454075
PMC: 9027896.
DOI: 10.3390/biom12040486.
Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
Mehew J, Johnson R, Roberts D, Griffiths A, Harvala H
Transfus Med. 2022; 32(4):327-337.
PMID: 35434868
PMC: 9115414.
DOI: 10.1111/tme.12868.
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer.
Focosi D, Rosellini A, Spezia P, Macera L, Lanza M, Paolicchi A
J Clin Virol Plus. 2022; 1(3):100035.
PMID: 35262018
PMC: 8349435.
DOI: 10.1016/j.jcvp.2021.100035.
The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review.
Shokri P, Golmohammadi S, Noori M, Nejadghaderi S, Carson-Chahhoud K, Safiri S
Rev Med Virol. 2022; 32(1):e2247.
PMID: 34997677
PMC: 8209917.
DOI: 10.1002/rmv.2247.
ABO and Rhesus Blood Groups in Acute Puumala Hantavirus Infection.
Tietavainen J, Laine O, Makela S, Huhtala H, Porsti I, Vaheri A
Viruses. 2021; 13(11).
PMID: 34835077
PMC: 8621274.
DOI: 10.3390/v13112271.
Relationship between blood type and outcomes following COVID-19 infection.
Kim Y, Latz C, DeCarlo C, Lee S, Png C, Kibrik P
Semin Vasc Surg. 2021; 34(3):125-131.
PMID: 34642032
PMC: 8286549.
DOI: 10.1053/j.semvascsurg.2021.05.005.
A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients.
Gozman L, Perry K, Nikogosov D, Klabukov I, Shevlyakov A, Baranova A
Front Genet. 2021; 12:709388.
PMID: 34603376
PMC: 8484761.
DOI: 10.3389/fgene.2021.709388.
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors.
Focosi D, Franchini M, Pirofski L, Burnouf T, Fairweather D, Joyner M
Viruses. 2021; 13(8).
PMID: 34452459
PMC: 8402718.
DOI: 10.3390/v13081594.
ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients.
Hermel D, Spierling Bagsic S, Costantini C, Mason J, Gahvari Z, Saven A
Future Sci OA. 2021; 7(8):FSO735.
PMID: 34290882
PMC: 8204818.
DOI: 10.2144/fsoa-2021-0045.
Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID-19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV-2.
Matzhold E, Berghold A, Bemelmans M, Banfi C, Stelzl E, Kessler H
Transfusion. 2021; 61(9):2736-2745.
PMID: 34151460
PMC: 8447157.
DOI: 10.1111/trf.16567.
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.
Peng H, Rhind S, Beckett A
JMIR Public Health Surveill. 2021; 7(4):e25500.
PMID: 33825689
PMC: 8245055.
DOI: 10.2196/25500.
Precision Medicine and Public Health: New Challenges for Effective and Sustainable Health.
Traversi D, Pulliero A, Izzotti A, Franchitti E, Iacoviello L, Gianfagna F
J Pers Med. 2021; 11(2).
PMID: 33669364
PMC: 7920275.
DOI: 10.3390/jpm11020135.
Anti-A and SARS-CoV-2: an intriguing association.
Dutra V, Bonet-Bub C, Yokoyama A, Achkar R, Machado R, Assuncao M
Vox Sang. 2021; 116(5):557-563.
PMID: 33650690
PMC: 8013368.
DOI: 10.1111/vox.13044.
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of....
Wendel S, Fontao-Wendel R, Fachini R, Candelaria G, Scuracchio P, Achkar R
Transfusion. 2021; 61(5):1447-1460.
PMID: 33604884
PMC: 8013380.
DOI: 10.1111/trf.16323.
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group.
Goel R, Bloch E, Pirenne F, Al-Riyami A, Crowe E, Dau L
Vox Sang. 2021; 116(8):849-861.
PMID: 33578447
PMC: 8014128.
DOI: 10.1111/vox.13076.
ABO phenotype and SARS-CoV-2 infection: Is there any correlation?.
Mathew A, E V, Pai S, Kishore A, Pai V, Chandrashekar K
Infect Genet Evol. 2021; 90:104751.
PMID: 33540085
PMC: 8035048.
DOI: 10.1016/j.meegid.2021.104751.